Jacobson Pharma Oncotype DX® Breast Recurrence Score Background: The Oncotype DX® is a genomic-based diagnostic test that predicts the likelihood of chemotherapy benefit and 10-year risk of distant recurrence of certain patients with early-stage breast cancer. It can guide the patient’s treatment decisions, and potentially avoid unnecessary and harmful chemotherapy treatments. The Oncotype DX® is …
Jacobson Pharma Oncotype DX® Breast Recurrence Score Read More »